INTERNATIONAL PATENT: NUCMITO PHARMACEUTICALS COMPANY LIMITED FILES APPLICATION FOR "RXR-ALPHA MODULATORS FOR TREATING MALIGNANCY"

GENEVA, March 17 -- NUCMITO PHARMACEUTICALS COMPANY LIMITED (882-6 LianTing Road, Unit 701, Xiamen (XiangAn) Torch High-tech Zone, XiangAn DistrictXiamen, Fujian 361000) filed a patent application (PCT/CN2024/117106) for "RXR-ALPHA MODULATORS FOR TREATING MALIGNANCY" on Sep 05, 2024. With publication no. WO/2025/051192, the details related to the patent application was published on Mar 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ZHANG, Xiaokun (882-6 LianTing Road, Unit 701, Xiamen (XiangAn) Torch High-tech Zone, XiangAn DistrictXiamen, Fujian 361000), ZHOU, Yuqi (882-6 LianTing Road...